Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | EUR 123.76B | 14.3x | -0.58 | EUR 98.74 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
EssilorLuxottica | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 98.68B | 42.7x | -12.41 | EUR 216.70 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 18.26B | 111.5x | -1.72 | EUR 187.75 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.3% Upside | Upgrade to Pro+ | |
Biomerieux | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 12.11B | 29.3x | 4.46 | EUR 102.60 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | EUR 9.27B | 13.7x | 0.28 | EUR 112.80 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Eurofins Scientific | Paris | Healthcare | Healthcare Providers & Services | EUR 8.77B | 33.3x | -1.35 | EUR 45.54 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.3% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | EUR 2.95B | 20.9x | 1.09 | EUR 352 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Ramsay Generale De Sante | Paris | Healthcare | Healthcare Providers & Services | EUR 1.48B | -27.4x | 0.13 | EUR 13.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emeis | Paris | Healthcare | Healthcare Providers & Services | EUR 987.92M | 0.4x | 0.01 | EUR 6.14 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vetoquinol | Paris | Healthcare | Pharmaceuticals | EUR 941.87M | 20x | -1.03 | EUR 79.60 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Clariane SE | Paris | Healthcare | Healthcare Providers & Services | EUR 726.10M | -0x | 0 | EUR 2.05 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.3% Downside | Upgrade to Pro+ | |
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 605.62M | -3x | -1.89 | EUR 9.57 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boiron | Paris | Healthcare | Pharmaceuticals | EUR 566.88M | 24x | -0.47 | EUR 32.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | EUR 440.39M | -17.1x | -0.57 | EUR 15.14 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.9% Upside | Upgrade to Pro+ | |
Valneva | Paris | Healthcare | Biotechnology & Medical Research | EUR 422.49M | -11x | 0.04 | EUR 2.60 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guerbet | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 402.86M | 12.3x | 0.07 | EUR 31.95 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | EUR 340.28M | -1.3x | 0 | EUR 3.67 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16% Downside | Upgrade to Pro+ | |
Genfit | Paris | Healthcare | Biotechnology & Medical Research | EUR 261.99M | 11.7x | 0.07 | EUR 5.26 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | EUR 259.13M | 42.9x | -1.74 | EUR 25.80 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
LNA Sante SA | Paris | Healthcare | Healthcare Providers & Services | EUR 248.47M | 10.4x | EUR 24.30 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.8% Upside | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | EUR 214.21M | -1.2x | 0.23 | EUR 2.46 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 209.48M | 4.4x | 0.02 | EUR 9.64 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | |
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 205.45M | -6.5x | -0.15 | EUR 0.68 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | EUR 186.77M | -5.1x | -0.11 | EUR 3.94 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | EUR 171.16M | -1.7x | -0.06 | EUR 1.71 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumibird SA | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 153.99M | 23.6x | -0.78 | EUR 6.90 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplitude Surgical SAS | Paris | Healthcare | Healthcare Equipment & Supplies | EUR 151.64M | 3.5x | EUR 3.16 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | EUR 140.93M | -6.2x | -0.19 | EUR 9.25 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.8% Downside | Upgrade to Pro+ | |
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 137.78M | -4x | -0.09 | EUR 1.70 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bastide Le Confort | Paris | Healthcare | Healthcare Providers & Services | EUR 130.92M | 19.7x | EUR 17.92 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |